کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3238904 1205976 2015 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Ionising radiation exposure in patients with circular frame treatment of distal tibial fractures
ترجمه فارسی عنوان
قرار گرفتن در معرض تابش یونیزه در بیماران مبتلا به شکستگی های دیستال تیتیال با درمان قاب مدور
کلمات کلیدی
تابش؛ دیاستال؛ تیبیا؛ قاب مدور؛ شکستگی؛ سرطان زا؛ توموگرافی کامپیوتری
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی طب اورژانس
چکیده انگلیسی

Total radiation exposure accumulated during circular frame treatment of distal tibial fractures was quantified in 47 patients treated by a single surgeon from February 2007 until Oct 2010. The radiation exposures for all relevant radiology procedures for the distal tibial injury were included to estimate the radiation risk to the patient.The median time of treatment in the frame was 169 days (range 105–368 days). Patients underwent a median of 13 sets of plain radiographs; at least one intra operative exposure and 16 patients underwent CT scanning. The median total effective dose per patient from time of injury to discharge was 0.025 mSv (interquartile range 0.013–0.162 and minimum to maximum 0.01–0.53). The only variable shown to be an independent predictor of cumulative radiation dose on multivariate analysis was the use of CT scanning. This was associated with a 13-fold increase in overall exposure.Radiation exposure during treatment of distal tibial fractures with a circular frame in this group was well within accepted safe limits. The fact that use of CT was the only significant predictor of overall exposure serves as a reminder to individually assess the risk and utility of radiological investigations on an individual basis. This is consistent with the UK legal requirements for justification of all X-ray imaging, as set out in the Ionising Radiation (Medical Exposure) Regulations 2000 [1].

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Injury - Volume 46, Issue 8, August 2015, Pages 1597–1600
نویسندگان
, , , , ,